ES2113356T3 - Peptidos con un determinante antigenico caracteristico para alfa-1-micro-globulina. - Google Patents

Peptidos con un determinante antigenico caracteristico para alfa-1-micro-globulina.

Info

Publication number
ES2113356T3
ES2113356T3 ES91113161T ES91113161T ES2113356T3 ES 2113356 T3 ES2113356 T3 ES 2113356T3 ES 91113161 T ES91113161 T ES 91113161T ES 91113161 T ES91113161 T ES 91113161T ES 2113356 T3 ES2113356 T3 ES 2113356T3
Authority
ES
Spain
Prior art keywords
amino acids
microglobulin
sequence
alpha
human alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91113161T
Other languages
English (en)
Inventor
Erhard Dr Kopetzki
Christian Dr Klein
Dieter Dr Mangold
Werner Dr Stock
Reiner Dr Schlipfenbacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6411730&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2113356(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2113356T3 publication Critical patent/ES2113356T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

EL PEPTIDO, CONFORME LA INVENCION, CON UNA LONGITUD DE 40 AMINOACIDOS COMO MAXIMO, Y QUE CONTIENE UNA SECUENCIA DE 6 AMINOACIDOS, COMO MINIMO, PROCEDENTE DE LA SECUENCIA PARCIAL DE AMINOACIDOS, ENTRE LOS AMINOACIDOS 144 Y 183 DE LA (ALFA)-1-MICROGLOBULINA HUMANA Y/O UNA SECUENCIA DE 6 AMINOACIDOS, COMO MINIMO, PROCEDENTE DE LA SECUENCIA PARCIAL DE AMINOACIDOS, ENTRE LOS AMINOACIDOS 1 Y 20 DE LA (ALFA)1-MICROGLOBULINA HUMANA. UN ANTICUERPO, CONFORME LA INVENCION, ES CAPAZ DE LIGAR DE FORMA ESPECIFICA TANTO CON UNO DE LOS PEPTIDOS CONFORMES LA INVENCION, COMO CON 1-MICROGLOBULINA HUMANA. PARA LA DETERMINACION DE (ALFA)1-MICROGLOBULINA HUMANA EN UN LIQUIDO DE MUESTRA, MEDIANTE UN ENSAYO INMUNOLOGICO, EL LIQUIDO DE MUESTRA SE PONE EN CONTACTO SIMULTANEAMENTE, O SECUENCIALMENTE, CON CANTIDADES DEFINIDAS DE LOS COMPONENTES ANTICUERPO Y PEPTIDO, ESTANDO MARCADO UNO DE LOS COMPONENTES Y LLEVANDOSE A CABO LA DETERMINACION A TRAVES DE ESTE MARCADO.
ES91113161T 1990-08-06 1991-08-05 Peptidos con un determinante antigenico caracteristico para alfa-1-micro-globulina. Expired - Lifetime ES2113356T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4024919A DE4024919A1 (de) 1990-08-06 1990-08-06 Peptide mit fuer (alpha)1-mikroglobulin charakteristischer antigener determinante

Publications (1)

Publication Number Publication Date
ES2113356T3 true ES2113356T3 (es) 1998-05-01

Family

ID=6411730

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91113161T Expired - Lifetime ES2113356T3 (es) 1990-08-06 1991-08-05 Peptidos con un determinante antigenico caracteristico para alfa-1-micro-globulina.

Country Status (16)

Country Link
US (1) US6153192A (es)
EP (1) EP0470565B1 (es)
JP (1) JP2777489B2 (es)
KR (1) KR940001712B1 (es)
AT (1) ATE161851T1 (es)
AU (1) AU638155B2 (es)
CA (1) CA2048305A1 (es)
DE (2) DE4024919A1 (es)
ES (1) ES2113356T3 (es)
FI (1) FI913714A (es)
IE (1) IE912707A1 (es)
IL (1) IL99047A0 (es)
NO (1) NO913037L (es)
NZ (1) NZ239246A (es)
PT (1) PT98589A (es)
ZA (1) ZA916139B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0699906B1 (de) 1994-07-25 2002-04-24 Roche Diagnostics GmbH Verfahren zum Nachweis der Kontamination einer Oberfläche mit einem Analyten
DE4439429C2 (de) * 1994-07-25 1997-11-20 Boehringer Mannheim Gmbh Verfahren zum Nachweis der Kontamination einer Oberfläche mit einem Analyten
DE19622503C2 (de) * 1996-06-05 1998-07-09 Securetec Sicherheitstechnolog Verfahren zum Nachweis von Analyten auf einer Oberfläche
US20030195707A1 (en) * 2000-05-25 2003-10-16 Schork Nicholas J Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20020077775A1 (en) * 2000-05-25 2002-06-20 Schork Nicholas J. Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
JP2005511012A (ja) * 2001-08-10 2005-04-28 セローノ ジェネティクス インスティテュート ソシエテ アノニム ヒトｃＤＮＡおよびタンパク質およびその使用
AT501069A1 (de) * 2001-08-20 2006-06-15 Walter Ing Pils Vorrichtung und verfahren zum nachweis eines analyten
JP5749947B2 (ja) * 2011-03-11 2015-07-15 学校法人北里研究所 ネコ由来α１ミクログロブリンの測定方法および測定キット、ならびに、そのための抗体および抗体産生細胞株
CN109942703A (zh) * 2019-03-25 2019-06-28 上海睿康生物科技有限公司 α1-微球蛋白多克隆抗体的制备及α1-微球蛋白检测试剂盒
CN109998055B (zh) * 2019-04-09 2022-03-25 黑龙江省科学院大庆分院 一种汉麻籽抗氧化多肽咀嚼片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56106153A (en) * 1980-01-29 1981-08-24 Fujirebio Inc Method for determination of alpha1-microglobulin by enzyme immunity measurement method
GB2084317B (en) * 1980-09-30 1984-01-18 Erba Farmitalia Antigen-linked competitive enzymeimmunoassay
US5030565A (en) * 1983-08-17 1991-07-09 Scripps Clinic And Research Foundation Polypeptide-induced monoclonal receptors to protein ligands
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides

Also Published As

Publication number Publication date
AU638155B2 (en) 1993-06-17
IE912707A1 (en) 1992-02-12
DE59108915D1 (de) 1998-02-12
KR920004415A (ko) 1992-03-27
JP2777489B2 (ja) 1998-07-16
CA2048305A1 (en) 1992-02-07
DE4024919A1 (de) 1992-02-13
IL99047A0 (en) 1992-07-15
NO913037D0 (no) 1991-08-05
JPH04244099A (ja) 1992-09-01
PT98589A (pt) 1992-06-30
AU8159991A (en) 1992-03-05
ZA916139B (en) 1992-04-29
NZ239246A (en) 1992-10-28
NO913037L (no) 1992-02-07
ATE161851T1 (de) 1998-01-15
KR940001712B1 (ko) 1994-03-05
EP0470565A1 (de) 1992-02-12
EP0470565B1 (de) 1998-01-07
FI913714A0 (fi) 1991-08-05
US6153192A (en) 2000-11-28
FI913714A (fi) 1992-02-07

Similar Documents

Publication Publication Date Title
DE58905081D1 (de) Verfahren zur bestimmung eines proteins nach dem prinzip des fluoreszenz-polarisations immunoassays.
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
NO901899L (no) Hiv-peptider, syntetiske hiv-antigener og immunoanalysekit
ATE98776T1 (de) Monoklonale antikoerper fuer hba1c.
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
ATE120549T1 (de) Verfahren zur bestimmung von hiv-antikörpern.
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
ES2113356T3 (es) Peptidos con un determinante antigenico caracteristico para alfa-1-micro-globulina.
IL132414A0 (en) Type alpha platelet derived growth factor receptor gene
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
ATE142224T1 (de) Peptide von sm-d-antigen, deren benützung zum nachweis von disseminierten lupus-erythemateux
FI943218A0 (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
KR890009417A (ko) 모노크로날 항체의 제조방법 및 그것의 이용방법
KR870001470A (ko) 인체 인터로이킨-2의 측정방법 및 측정시약
DE69333683D1 (de) Antikörper-testbesteck zur bestimmung von amylin
TH10365EX (th) วิธีการใหม่สำหรับวินิจฉัยวัณโรค
ATE193021T1 (de) Lipoprotein (a)-peptide und deren verwendung
KR960035021A (ko) B형 간염 표면항원 preS2의 에피토프 태깅을 이용한 단백질의 면역화학적 분석 방법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 470565

Country of ref document: ES